Silexion Therapeutics Corp
For the period ended Dec 31, 2024. Filed Mar 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 18, 2025
SLXN$0.11-12.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
. Financial Statements and Supplementary Data.
Please see the F- pages to this Annual Report, which contain the consolidated financial statements of the Company and its subsidiaries as of December 31, 2024 and 2023, and for the years ended December 31, 2024 and 2023.
Item 9
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.